HCM
CLB icon

Holland Capital Management’s Core Laboratories CLB Stock Holding History

Holland Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-15,300
Closed -$2.24M – 70
2014
Q3 		$2.24M Sell
15,300
-2,250
-13% -$347K 0.05% 66
2014
Q2 		$2.93M Hold
17,550
– – 0.06% 67
2014
Q1 		$3.48M Hold
17,550
– – 0.08% 66
2013
Q4 		$3.35M Hold
17,550
– – 0.07% 64
2013
Q3 		$2.97M Sell
17,550
-8,800
-33% -$1.37M 0.07% 63
2013
Q2 		$4M Buy
+26,350
New +$3.73M 0.1% 60

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Holland Capital Management's CLB Position: Q4 2014 in Review

Holland Capital Management sold out of Core Laboratories (CLB) in Q4 2014, closing a stake of 15,300 shares — an estimated $2.24M sold.

Holland Capital Management first reported a position in CLB in Q2 2013 and held it in 6 quarters. The position peaked at $4M in Q2 2013. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2014.

  • Holland Capital Management reported no remaining Core Laboratories position as of Q4 2014 after selling out during the quarter.
  • Holland Capital Management sold 15,300 Core Laboratories shares in Q4 2014, an estimated $2.24M.
  • Holland Capital Management first reported a position in Core Laboratories in Q2 2013 and held it in 6 quarters.
  • Holland Capital Management's Core Laboratories position peaked at $4M in Q2 2013.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2014.

Based on Holland Capital Management's 13F filing for Q4 2014, filed 29 Jan 2015.